Cardiome -- CRME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME

CRME 2.330

-2.1%

May 16 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (200)	8/31/2007 9:26:27 AM
From: kenhott	Read Replies (1) of 285

I actually don't like to be negative. I know, hard to believe to some. The way IV would be used, I just can't buy into the idea that the drug is new so therefore it should be looked at by the Cardiovascular and Renal Drugs Advisory Committee. I went and looked at the history of the meetings for this committee for the last x meetings. Didn't give me a warm feeling. This is now to me a short candidate. Especially after the phase 2b oral data. Of course the usual disclaimer about if I actually know what I am doing, I would be.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next